ALTERED CD20 CONFORMATION AT THE CELL SURFACE OF RITUXIMAB REFRACTORY TUMOR CELLS - A NOVEL MECHANISM OF RITUXIMAB RESISTANCE

被引：0
|
作者：
Shimada, K. [1 ]
Tomita, A. [2 ]
Tokunaga, T. [2 ]
Iriyama, C. [2 ]
Kinoshita, T. [2 ]
Glennie, M. [1 ]
Johnson, P. [1 ]
Naoe, T. [2 ]
机构：
[1] Univ Southampton, Sch Med, Gen Hosp, Canc Sci Div, Southampton, Hants, England
[2] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [1] Structural changes in the internal domain of CD20 antigen associated with the emergence of rituximab resistance: Effects of proteasome inhibition in CD20 structure and rituximab anti-tumor activity in rituximab-resistant cell lines (RRCL).
    Hernandez-Ilizaliturri, FJ
    Olejniczak, SH
    Knight, J
    Czuczman, MS
    [J]. BLOOD, 2005, 106 (11) : 425A - 425A
  • [2] Mutation of CD20 gene causes resistance to therapy with rituximab
    Terui, Y
    Sakurai, T
    Mishima, Y
    Mishima, Y
    Yokoyama, M
    Hatake, K
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 78 - 79
  • [3] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    [J]. BLOOD, 2006, 108 (11) : 155B - 155B
  • [4] Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases
    Reis, J.
    Aguiar, F.
    Brito, I
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2016, 41 (01): : 45 - 55
  • [5] High, stable and homogenous CD20 expression for efficient rituximab-induced elimination of CD20+ alloreactive donor T cells in the novel CD20/Rituximab 'suicide' system
    van Meerten, T
    Claessen, MJ
    Hagenbeek, A
    Ebeling, S
    [J]. BLOOD, 2004, 104 (11) : 485A - 485A
  • [6] Loss of CD20 expression on CLL cells following treatment with rituximab
    Poirot, Brigitte
    Chedani, Hicham
    Abbed, Karim
    Tertian, Gerard
    Raphael, Martine
    Besson, Caroline
    [J]. HEMATOLOGIE, 2010, 16 (01): : 92 - 95
  • [7] Structural changes in the internal domain of the CD20 antigen is associated with the development of rituximab resistance: Effects on signaling and redistribution of CD20 into lipid raft domains in rituximab-resistant cell lines (RRCL).
    Gowda, AC
    Hernandez-Ilizaliturri, FJ
    Connolly, G
    Czuczman, MS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 163S - 163S
  • [8] Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance
    Henry, Carole
    Deschamps, Marina
    Rohrlich, Pierre-Simon
    Pallandre, Jean-Rene
    Remy-Martin, Jean-Paul
    Callanan, Mary
    Traverse-Glehen, Alexandra
    GrandClement, Camille
    Garnache-Ottou, Francine
    Gressin, Remy
    Deconinck, Eric
    Salles, Gilles
    Robinet, Eric
    Tiberghien, Pierre
    Borg, Christophe
    Ferrand, Christophe
    [J]. BLOOD, 2010, 115 (12) : 2420 - 2429
  • [9] Rituximab with peripheral blood stem cell transplantation in CD20 lymphoproliferative disorders
    Mazza, P
    Palazzo, G
    Amurri, B
    Pricolo, G
    Prudenzano, A
    Stani, L
    [J]. HAEMATOLOGICA, 2001, 86 (10) : 1104 - 1105
  • [10] Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface
    Al-Zoobi, Loubna
    Salti, Suzanne
    Colavecchio, Anna
    Jundi, Malek
    Nadiri, Amal
    Hassan, Ghada S.
    El-Gabalawy, Hani
    Mourad, Walid
    [J]. INTERNATIONAL IMMUNOLOGY, 2014, 26 (08) : 451 - 465
12345